NCT04212455 A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
| NCT ID | NCT04212455 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangdong Provincial People's Hospital |
| Condition | Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2022-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2020-01-01 with a primary completion date of 2022-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.
Eligibility Criteria
Inclusion Criteria: * ≥18 years old * In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension) Exclusion Criteria: * \<18 years old * Unsigned informed consent * Pregnant Women and Lactation
Contact & Investigator
Feng Ying-qing, PhD
STUDY DIRECTOR
Guangdong Provincial People's Hospital
Frequently Asked Questions
Who can join the NCT04212455 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04212455 currently recruiting?
Yes, NCT04212455 is actively recruiting participants. Contact the research team at 651792209@qq.com for enrollment information.
Where is the NCT04212455 trial being conducted?
This trial is being conducted at Guangzhou, China, Guangzhou, China.
Who is sponsoring the NCT04212455 clinical trial?
NCT04212455 is sponsored by Guangdong Provincial People's Hospital. The principal investigator is Feng Ying-qing, PhD at Guangdong Provincial People's Hospital. The trial plans to enroll 50,000 participants.